Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Tags › Posts tagged Pharmaceutical Industry

Tag: Pharmaceutical Industry

Valeant Pharmaceuticals Inc. said late Wednesday that federal prosecutors are seeking information on the drug developer's drug pricing, distribution and patient assistance program. (Ryan Remiorz/The Canadian Press via AP, File) Healthcare

Drug maker faces federal probe over high prices

Robert King · October 15, 2015 2:28 pm
Clinton also would impose federally dictated prices on new medicines by forcing drug makers to calculate, using some sort of pseudo-scientific formula, each new drug's R&D cost. (Bloomberg/Daniel Acker) Healthcare

Hillary on drugs: Bad prescription

John Graham · October 14, 2015 4:01 am
Kaiser estimates that the average Part D premium, Medicare's prescription drug plan, will increase from $36 to $41 per month next year. (AP file photo/Morry Gash) Healthcare

Medicare drug plan premiums to shoot up next year

Robert King · October 13, 2015 3:49 pm
Democratic presidential candidate, Sen. Bernie Sanders won't vote for Robert Califf as the new commissioner of the Food and Drug Administration. (AP Photo/Michael Dwyer) Healthcare

Sanders won’t back Obama’s pick for FDA chief

Robert King · October 9, 2015 6:05 pm
Democratic presidential candidate Sen. Bernie Sanders, I-Vt., left, accompanied by Rep. Elijah Cummings, D-Md., said that Turing Pharmaceuticals' Martin Shkreli hasn't lowered the price of a drug that he jacked up 5,000 percent. (AP Photo/Susan Walsh) Healthcare

Lawmakers ‘sickened’ over drug CEO

Robert King · October 9, 2015 4:44 pm
Trade ministers from 12 Pacific Rim nations negotiating the Trans-Pacific Partnership agreement pose for a group photo at a meeting in Lahaina, Hawaii on Thursday, July 30, 2015. (AP Photo/Audrey McAvoy) Op-Eds

Early signals point to big wins in trade deal

Alex Armlovich · October 9, 2015 4:01 am
Economy

Wall Street drubbed drug industry, but it won’t last

Robert King · October 8, 2015 4:01 am
Sen. Joe Manchin, D-W.Va., said Tuesday that he wants a commitment that the agency will be held responsible on opioid approvals after several controversial decisions. (AP Photo) Healthcare

‘Rogue’ FDA could stoke painkiller abuse: Senator

Robert King · October 7, 2015 4:01 am
The White House's last-minute compromise on drug copyright protections in the Trans-Pacific Partnership appears to have pleased nobody. (AP Photo) Healthcare

Why everybody hates the drug deal in the trade pact

Robert King · October 6, 2015 4:01 am
Nationwide there are nearly 2 million people living with hepatitis B and 3.2 million who have hepatitis C. (AP Photo/Paul Sakuma) Healthcare

Health insurers accused of discrimination

Robert King · October 5, 2015 6:19 pm
All of the bills to lower costs were filed earlier this year, but so far none has advanced out of their respective legislative committees. (AP Photo/Kelley McCall) Healthcare

States try to rein in pricey drugs

Robert King · October 3, 2015 10:28 am
Called the Improving Regulatory Transparency for New Medical Therapies Act, the bipartisan bill from Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., was approved unanimously by the Health, Education, Labor and Pensions Committee and next goes before the full Senate. (AP Photo/Toby Talbot, File) Healthcare

Senate panel OKs drug competition bill

Paige Winfield Cunningham · September 30, 2015 8:16 pm
Advertisement
  • ‹Previous page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 142
  • ›Next page
Page 124 of 142
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement